Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy

A technology of diabetic cardiomyopathy and composition, which is applied in the application field of pharmaceutical composition in the preparation of drugs for preventing and treating diabetic cardiomyopathy, and can solve problems such as the role of pharmaceutical composition in preventing and treating diabetic cardiomyopathy

Active Publication Date: 2012-12-12
GUANGZHOU BAIYUNSHAN ZHONGYI PHARMA COMPANY
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] However, neither the patent nor related documents mentioned that the pharm...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy
  • Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy
  • Application of pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] In order to clarify the curative effect of pharmaceutical composition of the present invention for the treatment of diabetic cardiomyopathy, the present invention will be further elaborated by the following examples:

[0027] 1. Experimental samples:

[0028]1.1 Sample name: Xiaoke Pill A, which is the pharmaceutical composition of the present invention, preparation method: refer to the preparation method of "Chinese Pharmacopoeia" 2010 edition Xiaoke Pill, according to the weight ratio of the pharmaceutical composition of the present invention, that is, Rehmannia glutinosa 636 parts by weight, Radix Astragalus 212 parts by weight, 106 parts by weight of Chinese yam, 1060 parts by weight of kudzu root, 1060 parts by weight of trichosanthin, 1060 parts by weight of corn silk, and 212 parts by weight of Schisandra chinensis. Add Pueraria root, rehmannia glutinosa, corn silk and trichosanthemi to decoct for 5 hours, filter, and concentrate the filtrate to an appropriate am...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of a pharmaceutical composition in preparing medicines used for preventing and treating diabetic cardiomyopathy. The active component of the pharmaceutical composition is mainly prepared from the medicine materials of: rehmannia, Mongolian milkvetch root, common yam rhizome, lobed kudzuvine root, snakegourd root, corn stigma, and kadsura japonica. With other currently known oral hypoglycemic western medicines such as glibenclamide or metformin, the pharmaceutical composition can be prepared into oral composite preparations used for preventing and treating diabetic cardiomyopathy.

Description

technical field [0001] The invention relates to a new application of a pharmaceutical composition, in particular to an application of a pharmaceutical composition in the preparation of medicines for preventing and treating diabetic cardiomyopathy. Background technique [0002] Diabetic cardiomyopathy is one of the main complications of diabetes. It refers to a disease state in which the primary damage of cardiomyocytes in diabetic patients causes extensive structural abnormalities, and eventually causes ventricular hypertrophy, diastolic and / or systolic dysfunction. Rubler (Rubler) was first proposed in 1972. In recent years, a large number of studies have confirmed that diabetic cardiomyopathy is an independent pathophysiological state, microvascular disease is one of the important reasons for the occurrence and development of diabetic cardiomyopathy, and its occurrence has nothing to do with coronary artery blood supply disorder. The main clinical manifestation is congest...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/899A61K45/06A61P3/10A61P9/00A61K31/64
Inventor 刘菊妍吴长海周凤娇周杰邓慧敏杨威肖百全赖晓明卢素红项磊
Owner GUANGZHOU BAIYUNSHAN ZHONGYI PHARMA COMPANY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap